InMed Pharmaceuticals Inc (INM) — Financial Flexibility Index
InMed Pharmaceuticals Inc (INM) has a Financial Flexibility Index of 0.00x as of March 2026. Free cash flow of $-1.76 Million (operating CF $-1.76 Million minus capex $4.00) represents 0% of total liabilities ($2.24 Billion). Also explore InMed Pharmaceuticals Inc (INM) equity growth momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
InMed Pharmaceuticals Inc Financial Flexibility Index (2001–2025)
Historical Financial Flexibility Index trend for InMed Pharmaceuticals Inc across 25 annual periods. Check strategic asset allocation of InMed Pharmaceuticals Inc to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for InMed Pharmaceuticals Inc (2001–2025)
Year-by-year free cash flow to debt coverage for InMed Pharmaceuticals Inc. For the full company profile including market capitalisation, see market value of InMed Pharmaceuticals Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.66x | $-7.77 Million | $-7.77 Million | $2.92 Million | ▼ -36.3% |
| 2024 | -1.95x | $-6.98 Million | $-6.99 Million | $3.58 Million | ▲ +26.9% |
| 2023 | -2.67x | $-7.12 Million | $-7.28 Million | $2.67 Million | ▲ +18.1% |
| 2022 | -3.25x | $-15.54 Million | $-15.58 Million | $4.78 Million | ▲ +1.1% |
| 2021 | -3.29x | $-9.79 Million | $-9.79 Million | $2.97 Million | ▲ +13.6% |
| 2020 | -3.81x | $-7.33 Million | $-7.37 Million | $1.92 Million | ▲ +31.8% |
| 2019 | -5.59x | $-6.65 Million | $-6.68 Million | $1.19 Million | ▼ -9.6% |
| 2018 | -5.10x | $-3.63 Million | $-3.68 Million | $713.02K | ▲ +38.2% |
| 2017 | -8.25x | $-2.35 Million | $-2.37 Million | $284.24K | ▼ -877.4% |
| 2016 | -0.84x | $-385.19K | $-386.07K | $456.17K | ▲ +96.7% |
| 2015 | -25.64x | $-1.60 Million | $-1.61 Million | $62.51K | ▼ -181.1% |
| 2014 | -9.12x | $-639.35K | $-641.38K | $70.11K | ▼ -1042.9% |
| 2013 | -0.80x | $-39.26K | $-39.26K | $49.20K | ▲ +79.6% |
| 2012 | -3.92x | $-174.62K | $-174.62K | $44.59K | ▲ +67.8% |
| 2011 | -12.16x | $-562.06K | $-562.06K | $46.20K | ▼ -7854.5% |
| 2010 | -0.15x | $-195.42K | $-195.42K | $1.28 Million | ▼ -260.5% |
| 2009 | 0.10x | $100.48K | $100.48K | $1.05 Million | ▲ +115.6% |
| 2008 | -0.61x | $-926.30K | $-951.15K | $1.52 Million | ▲ +40.3% |
| 2007 | -1.02x | $-1.38 Million | $-1.40 Million | $1.35 Million | ▼ -101.2% |
| 2006 | -0.51x | $-577.40K | $-577.40K | $1.14 Million | ▼ -21.0% |
| 2005 | -0.42x | $-694.92K | $-702.23K | $1.66 Million | ▲ +30.0% |
| 2004 | -0.60x | $-468.75K | $-484.19K | $781.44K | ▲ +32.6% |
| 2003 | -0.89x | $-820.00K | $-844.62K | $921.99K | ▲ +94.1% |
| 2002 | -15.19x | $-1.13 Million | $-1.14 Million | $74.45K | ▼ -2661.5% |
| 2001 | 0.59x | $292.32K | $-471.69K | $493.02K | — |